Precision Antibody™ has an exclusive license agreement with trans-chromosomic (Tc) mice carrying mini-chromosomes with megabase-sized human immunoglobulin (Ig) loci. Precision Antibody™ has developed a proprietary
Precision Antibody™ contributes to the development of novel antibody reagents for the RAS signaling network The National Cancer Institute (NCI)’s RAS initiative has been working
COLUMBIA, Maryland, February 10, 2021: Precision Antibody™ and A&G Pharmaceutical are pleased to announce the publication, in PLOS One, of the results of their collaborative study
COLUMBIA, Maryland, September 7, 2020: A&G Pharmaceutical Inc., and its Custom Antibody Division Precision Antibody™’s Progranulin ELISA kit used to investigate the correlation between progranulin serum
COLUMBIA, Maryland, September 7, 2020: A&G Pharmaceutical Inc., and its Custom Antibody Division Precision Antibody™’s Progranulin ELISA kit used to investigate the correlation between progranulin
COLUMBIA, Maryland, August 31, 2020: A&G Pharmaceutical, Inc (A&G), with its Custom Antibody Division Precision Antibody™ has developed mouse monoclonal antibodies (mAbs) against COVID-19 antigens;
Precision Antibody™ is the forefront of the global Custom Antibody industry & it is led by the innovative minds in immunology and antibody development field.
